Skip to main content
Christopher DeRenzo, MD, Pediatric Hematology & Oncology, Memphis, TN

ChristopherCharlesDeRenzoMD

Pediatric Hematology & Oncology Memphis, TN

Pediatric Solid Tumor Oncology

Assistant Member, Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital

Dr. DeRenzo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. DeRenzo's full profile

Already have an account?

  • Office

    262 Danny Thomas Pl
    Memphis, TN 38105
    Phone+1 901-595-3300

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
  • Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens Hospital
    Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2008 - 2011
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2008

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2018 - 2025
  • TX State Medical License
    TX State Medical License 2014 - 2020
  • OH State Medical License
    OH State Medical License 2008 - 2012
  • UT State Medical License
    UT State Medical License 2011 - 2012
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Press Mentions

  • Improved CAR T Cell Homing Increases Efficacy of Osteosarcoma Treatment
    Improved CAR T Cell Homing Increases Efficacy of Osteosarcoma TreatmentAugust 8th, 2024
  • Improved Chemokine Homing Enhances CAR T--Cell Therapy for Osteosarcoma
    Improved Chemokine Homing Enhances CAR T--Cell Therapy for OsteosarcomaAugust 8th, 2024
  • Improved Chemokine Homing Enhances CAR T-cell Therapy in Preclinicals for Osteosarcoma
    Improved Chemokine Homing Enhances CAR T-cell Therapy in Preclinicals for OsteosarcomaAugust 8th, 2024